Home » Topics » BioWorld Science

BioWorld Science
RSS

Assembly Biosciences initiates phase IIa studies of ABI-H0731 for HBV

July 10, 2018

Promising interim data presented from phase I study of oral carbapenem SPR-994

July 10, 2018

Pivotal phase III trial of Pixuvri in B-cell NHL does not meet primary endpoint

July 10, 2018

New mutations in SLC25A24 gene found to cause Fontaine syndrome

July 10, 2018

Embryonic stem cells make helpful heart muscles

July 10, 2018

First human data presented for prostate cancer imaging agent [68Ga]PSMA-093

July 10, 2018

Compound CAR T cells targeting CLL1 and CD33 in refractory acute myeloid leukemia: phase I results

July 10, 2018

Researchers unveil NAXD gene as causative of a neurodegenerative disorder

July 10, 2018

pAAV.CMV.miR204 shows protective effect on photoreceptors in models of inherited retinal disease

July 10, 2018

New hSTING agonists presented as cancer immunotherapy agents

July 10, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...